Calculus Bovis Sativus
Neuromyelitis Optica Spectrum Disorder
Tongji HospitalN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
18 Active assets in the Neuromyelitis Optica Spectrum Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PREDNISONE TABLETS Fred Hutchinson Cancer Center | Phase 2 | CCC |
Cytosin-Arabinosid Fred Hutchinson Cancer Center | Phase 2 | CCC |
Anti-Thymoglobulin, Rabbit Fred Hutchinson Cancer Center | Phase 2 | CCC |
CARMUSTINE Fred Hutchinson Cancer Center | Phase 2 | CCC |
ETOPOSIDE Fred Hutchinson Cancer Center | Phase 2 | CCC |
View all 20 →
Same molecule, other indications
Calculus Bovis Sativus is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →